Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia
Shivani Satish Wagh takes on the role of Joint Managing Director
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
Campaign launched to spread awareness regarding dengue prevention and control
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Shares and American Depositary Shares of Olink for $26.00 per Share
Subscribe To Our Newsletter & Stay Updated
